Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Metrics Regulatory News (OMG)

Share Price Information for Oxford Metrics (OMG)

Share Price is delayed by 15 minutes
Get Live Data
46.00    -2.00 (-4.17%)
Bid:
46.10
Ask:
47.90
Spread: 1.80 (3.905%)
Market Cap: £51.49m
OMG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Metrics Share Chart

Vicon launches new Valkyrie solution

19 Jul 2022 07:00

RNS Number : 8772S
Oxford Metrics PLC
19 July 2022
 

19 July 2022

Oxford Metrics plc

 

("Oxford Metrics or the "Group")

 

Vicon launches new Valkyrie solution

 

Vicon's most advanced range ever will drive forward new ground-breaking motion capture applications

 

Oxford Metrics plc (LSE: OMG), the smart sensing software company, servicing life sciences, entertainment and engineering markets, is pleased to announce that Vicon, a world leader in motion measurement, has today launched Valkyrie, its new flagship solution, with four camera models delivering the world's highest quality motion capture system.

 

The Valkyrie system will capture motion more accurately to reality than ever before, powering a new wave of innovation and discovery across all of the Group's vertical markets. Designed to work in harmony with all of Vicon's powerful software solutions, Valkyrie completes a best-in-class ecosystem for motion capture users.

 

Valkyrie-enabled systems will power motion capture projects with robust data, without the need for further processing, with its enhanced features allowing Vicon's customers to focus on their work rather than the technology. The new flagship range, which includes a 26-megapixel (MP) model and a high-speed capture mode up to 2,000 Frames Per Second (FPS), will allow academics, scientists, and researchers to accurately track even the fastest moving subjects, and for filmmakers and game designers to create ever more realistic and immersive experiences.

 

Nick Bolton, CEO of Oxford Metrics said:

"More and more we need technologies that truly perceive and capture every dimension of our world in real-time. I am delighted to announce Vicon's ground-breaking new solution - Valkyrie. Valkyrie will capture motion more accurately and faithfully to real life, extending the Group's sensing capabilities and providing an innovative, improved interface between the real world and its virtual twin.

 

Whether it is medical researchers using our technology to analyse increasingly complex motion or filmmakers rapidly adopting virtual production techniques - our customers are at the cutting edge of the use of motion capture. With Valkyrie we will support their growing needs and demands with the most advanced motion capture systems ever seen, driving forward a new and exciting era of motion capture innovation and exploration."

 

The full Valkyrie range will service all of the Group's vertical markets and comprises:

 

· VK26 - offering the highest available resolution at 26MP and native full-frame 150FPS. VK26 can cover large volumes with incredible detail, ideal for demanding applications such as Virtual Production and in-camera VFX, enhancing Vicon's product bench in the Entertainment sector.

· VK16 - offering the highest frame rate per megapixel, at 16MP with a native full-frame 300FPS, designed to support complex biomechanical modelling and engineering use cases, further serving both life sciences and engineering markets.

· VK8 - offering both the highest native full-frame rate of 500FPS and the best cost per megapixel at 8MP. VK8 can capture the fastest moving athletes and objects including golf balls and gymnasts, extending Vicon's capabilities at the cutting edge of the elite sports and life sciences sectors.

· VK-X - supports the most convincing and responsive VR experiences and applications that utilise active markers; VK-X strengthens Vicon's technology stack in the visual effects and Virtual Reality sector, and the Location-based Entertainment (LBE) market.

 

 

For further information please contact:

 

Oxford Metrics +44 (0) 1865 261860

Nick Bolton, CEO

David Deacon, CFO

 

Numis Securities Limited +44 (0)20 7260 1000

Simon Willis / Hugo Rubinstein / Tejas Padalkar

 

FTI Consulting +44 (0)20 3727 1000

Matt Dixon / Jamille Smith / Jemima Gurney

 

About Oxford Metrics

 

Oxford Metrics develops software that enables the interface between the real world and its virtual twin. Our smart sensing software helps over 10,000 customers in more than 70 countries, including all of the world's top 10 games companies and all of the top 20 universities worldwide. Founded in 1984, we started our journey in healthcare, expanded into entertainment, winning an OSCAR® and an Emmy®, then moved into defence and engineering. We have a track record of creating value by incubating, growing and then augmenting through acquisition, unique technology businesses.

 

The Group trades through its market-leading division: Vicon. Vicon is a world leader in motion measurement analysis to thousands of customers worldwide, including Guy's Hospital, Industrial Light & Magic, MIT and NASA.

 

The Group is headquartered in Oxford with offices in California, Colorado, and Auckland. Since 2001, Oxford Metrics (LSE: OMG), has been a quoted company listed on AIM, a market operated by the London Stock Exchange. For more information about Oxford Metrics, visit www.oxfordmetrics.com

 

About Vicon

 

Academy Award®-winning Vicon is an innovator in motion capture and the world's largest supplier of motion measurement systems. Established in 1984, Vicon serves customers in visual effects, object tracking, virtual and augmented realities, engineering, broadcast, biomechanics, sports and clinical sciences. 

 

With thousands of customers world-wide, including Guy's Hospital, EA Sports, Bandai Namco, Sony, Dreamscape Immersive, MIT and NASA, the diverse applications for Vicon technology continues to grow.

 

More recently, Vicon has seen the demand for motion measurement going mainstream and applied to a broader range of applications than ever before with new markets including Location-based Virtual Reality and Elite Sports.

 

Vicon is a subsidiary of Oxford Metrics (LSE: OMG), the international smart sensing software company servicing government, life sciences, entertainment and engineering markets. For more information about Vicon, visit www.vicon.com.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFFRDDITLIF
Date   Source Headline
2nd Jun 20264:20 pmRNSTotal Voting Rights
2nd Jun 20267:00 amRNSNotice of Results and Investor Event
21st May 20265:35 pmRNSCompletion of Buyback Programme
20th May 20267:00 amRNSTransaction in Own Shares
19th May 202610:07 amRNSNotification of Major Holdings
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20269:57 amRNSNotification of Major Holdings
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:19 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 202611:26 amRNSNotification of Major Holdings
27th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTrading Update and Notice of Results
23rd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 202611:59 amRNSNotification of Transactions by a PDMR
13th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20265:17 pmRNSNotification of Major Holdings
24th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSNotification of Transactions by a PDMR and a PCA
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20268:13 amRNSShare Buyback Programme - Update
2nd Mar 20265:33 pmRNSTotal Voting Rights
26th Feb 20269:59 amRNSCorrection: Result of Annual General Meeting
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20265:19 pmRNSResult of AGM
25th Feb 20267:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.